Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
Meta Materials’ $100 Million Common Stock Offering
Lowenstein Sandler represented the sales agents in the offering. Meta Materials Inc. announced its At-The-Market sales agreement for the issuance of up to $100 million of...